Targeting DNMT3B in multiple myeloma: a novel epigenetic-based targeting approach that displays potent anti-myeloma activity and enhances sensitivity to standard of care agents
- Muylaert, C. (Speaker)
- De Bruyne, E. (Speaker)
Activiteit: Talk or presentation at a conference